Drug Profile
Research programme: neurological disorders therapeutics - Avineuro/ChemDiv
Alternative Names: AVN 0189; AVN 3085; AVN 3205; AVN-329; AVN-426Latest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator ChemDiv
- Developer Avineuro Pharmaceuticals
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for preclinical development in Neurological-disorders in USA
- 12 Sep 2016 Research programme for Neurological disorder therapeutics is still in Preclinical development for Neurological disorders in USA (Avineuro Pharmaceuticals pipeline, September 2016)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Neurological-disorders in USA